-
-
complement
- a series of proteins that work in a cascading fashion to generate important host defense mechanisms
- can be activated in 3 ways:
- 1. classical
- 2. alternative
- 3. MBL (mannan binding ligand)
-
classical complement pathway
- triggered by antibodies bound to antigens on the microbial surface
- results in the recruitment of inflammatory cells
-
What are the predominant activators of the classical pathway?
- antigen-antibody complexes
- this pathway is a major effector pathway of the humoral adaptive immune response
-
Classical Complement Pathway Cascade
- 1. when an antibody binds an antigen fragment, a region on it's Fc (heavy chain) becomes exposed & C1q may bind to it
- 2. immediately C1r & C1s bind to C1q (q --> r & s)
- 3. this triad = the enzyme C1 esterase
- 4. C1 esterase cleaves C4 --> C4a (released) & C4b (stays covalently bound)
- 5. C14b complex binds C2, which is cleaved by the C1 esterase --> C2a (released) & C2b (stays bound)
- 6. C14b2b splits C3 --> C3a & C3b
- 7. C14b2b3b splits C5 --> C5a and C5b
- 8. C5b stays attached to C14b2b3b & from there binds to C6
- 9. this initiates the formation of the MAC: C14b2b3b5b + C6, C7, C8, & C9
- ORDER: 1, 4, 2, 3, 5, 6-9
-
C1-inhibitor (C1-INH)
inhibits the binding of C1 to the Fc region of an antibody bound to an antigen
-
Membrane Attack Complex (MAC)
- made up of C14b2b3b5b + late components C6-9
- triggered by C3b attaching to membrane surfaces & cleaving C5 --> C5b sticks & the late components stick to IT
-
most important ways complement defends against infectious organisms:
- 1. production of opsonins: coating infected cells w/ Ig & C3b enhances the ability of macrophages + neutrophils to phagocytose them
- 2. chemotaxis of cells toward injury & production of anaphylatoxins: C3a & C5a induce local & systemic inflammatory responses
- 3. c8 & c9 direct killing/lysis of organisms
-
phagocytic activity of neutrophils, neutrophils w/ antibody, & neutrophils, antibody AND complement (C3b)
-
C3a & C5a
- stimulate inflammation by
- 1) attracting neutrophil polymorphs chemotactically to the site of infection
- 2) stimulating the release of anaphylatoxin (eg. histamine) by degranulating basophils + mast cells
-
C9
- late components/part of the MAC
- protein that forms pores in a pathogen's membrane through which fluid can rush, lysing the foreign cell
-
alternative complement pathway
- triggered by C3b binding directly to bacterial/viral products, especially lipopolysaccharide (LPS) aka endotoxin from the cell walls of gram - bacteria & some yeasts
- results in the opsonization of pathogens
-
Which parts of the alternative complement pathway are unique and which are also used by the classical complement pathway?
- UNIQUE: the serum factors B & D, and properdin (factor P)
- shared: C3, C3b, C5, C6, C7, C8, & C9
-
Why must activation of the alternative complement pathway be tightly controlled?
because C3b is normally present in the circulation in small amounts as a result of spontaneous hydrolysis of C3 - it's always primed & ready to go
-
Factor H & Factor I
two inhibitory proteins that constantly inactivate C3b, inhibiting the alternative complement pathway
-
C3BbBP
C3 convertase formed during activation of the alternative complement pathway after C3b has detected a foreign particle (eg. LPS) and complexed with/undergone a series of reactions involving factors B & D, properdin
-
lectin complement pathway (MBL)
- or mannan binding ligand complement pathway
- initiated when mannan-binding lectin binds to carbohydrates on the surface of microbes
- results in lysis & death of pathogens
- activation results in the cleavage of the classical complement pathway components C4 & C2 to form C4b2b
-
What proteins are important for the lectin complement pathway? (5)
- MBL (mannose binding lectin)
- MASP 1
- MASP 2
- C4
- C2
-
What kind of bacteria cannot activate the lectin complement pathway?
- gram positive
- they DO NOT have mannose on their surface
-
The alternative & lectin complement pathways are part of which immune system?
they are both effector arms of the INNATE immune system b/c they occurs in the absence of antibody
-
A deficiency in which complement protein would cause a more serious condition than missing a proteins that acts preliminarily in one of the 3 complement pathways?
C3 - because it functions in ALL 3 complement systems
-
SLE (systemic lupus erythematosus)
- caused by an absence of C1q, C2 or C4
- deficiency of these tend to cause autoimmunity due to an impaired ability to process & clear immune complexes
- bacterial infection is not an issue b/c the 2 nonclassical pathways can combat such immune disruptions
-
absence of C3 causes:
severe recurrent bacterial infections - none of the complement pathways can function
-
absence of C5 causes:
- bacterial infections (LESS severe than C3 deficiency)
- won't be able to make C5a --> can't punch holes in bacteria membranes
-
overwhelming Neisserial infections caused by:
- an absence of C5b --> C6, C7 or C8
- N. meningitidis & N. gonorrhea (gram -) cause an overwhelming infection because holes can't be punched in bacteria
- are normally disposed of by complement when they enter blood stream by formation of transmembrane pores
- without C5b --> C6, C7 or C8, bacteria can spread & infection may manifest in abnormal areas
- chemotaxis, anaphylaxis, opsonization still function normally, which is why these people are mostly not immunocompromised
-
absence of alternative pathway components leads to:
recurrent bacterial infections
-
infection predominantly in childhood is caused by:
absence of Lectin pathway proteins
-
pyogenic infections
- also a deficiency of the alternative pathway component properdin, or of factors B or D
- pyogenic = bacteria that cause pus
-
Hereditary Angioedema (HAE)
- a rare autosomal dominant genetic disorder caused by an inherited deficiency or dysfunction of the C1 inhibitor (C1-INH)
- C1 binding to Ig Fc is NOT inhibited
- there is uncontrolled cleavage of C2 & C4
- characterized by recurrent episodes of angioedema that most often affect the skin & the mucosal tissues of the upper respiratory and gastrointestinal tracts
-
-
acute inflammation
- the immediate and early response of vascularized, living tissue to injury
- in order for a tissue to be inflamed it has to be vascularized/living
-
causes of acute inflammation
- anything that causes tissue damage will invoke an acute inflammatory response; exposure to:
- pathogens (eg. bacteria, viruses, fungi)
- trauma
- extreme heat or cold (eg. burn/frostbite)
- caustic chemicals
- radiation (eg. UV light, sunburn)
- an aberrant immune response
-
What are the 5 cardinal symptoms of inflammation?
- redness, heat, swelling, pain, loss of function
- 1. Rubor: caused by vasodilation
- 2. Calor: as vessels dilate, more warm core blood from inside can move to the periphery
- 3. Tumor: swelling's caused by increased vascular permeability at the site of inflammation
- 4. Dolor
- 5. Functio laesa
-
What component of the vasculature at the site of tissue damage coordinates & modulates many activities associated with inflammation?
- the ENDOTHELIUM lining the vasculature
- modulates things such as blood flow, leukocyte adhesion, & leukocyte transmigration
-
Sequence of events in acute inflammation:
- 1. vasoconstriction: mediated by sensory nerve impulses to smooth muscle in blood vessel; only transient, lasts a few seconds
- 2. vasodilation: promoted by inflammatory mediators
- 3. increased blood flow: b/c of vasodilation there's less resistance & the BV has a larger lumed --> more warm core blood enters vessels at inflammation site
- 4. increased vascular permeability: promoted by inflammatory mediators, endothelial cells separate from each other
- 5. hemoconcentration + slowing of flow (stasis): blood is a liquid; with the endothelial cells separated from one another, plasma (liquid) leaks from the BV lumen to the surrounding interstitium, & remaining RBCs to sludge within the vessel
- 6. leukocyte trafficking: WBCs in blood vessel lumen attack to endoth. tissues & migrate into site of inflammation
-
leukocyte trafficking steps
- 1. capture
- 2. rolling
- 3. slow rolling
- 4. arrest
- 5. adhesion/strengthening/ spreading
- 6. intravascular crawling
- 7. transcellular migration
- 8. paracellular migration
- leukocyte trafficking is controlled by coordinated expression of soluble mediators and adhesion molecules
- these events occur sequentially; interruption of any ONE of these steps (w/ drugs, genetic mutation, or missing mediator) may decrease or halt inflammatory response
-
Where do soluble mediators involved in acute inflammation originate?
- plasma proteins: activated by proteolytic cleavage reactions
- synthesized by cells: pre-formed or synthesized de novo when needed
-
Which soluble mediators are pre-formed and stored in granules and which are synthesized de novo when they're needed?
- pre-formed in granules: histamine, serotonin [vasoactive amines]
- de novo: nitric oxide [NO], prostaglandins, leukotrienes
-
Histamine
- promotes vaso/veno/post-capillary dilation & increased vascular permeability
- activates endothelial cells to upregulate adhesion molecules
- is a vasoactive amine
- pre-formed mainly by mast cells (& basophils)
- is rapidly released upon cell activation
- by itself can cause most of the symptoms of acute inflammation
- *is an important mediator of type I hypersensitivity
-
What stimulates the RELEASE of histamine from mast cells or basophils?
- the interaction of an antigen w/ specific IgE molecules bound to the surface of mast cells or circulating basophils
- C5a or C3a binding to their individual receptors
- trauma
- temperature extremes
-
Serotonin
- promotes venodilation + increased vascular permeability
- activates capillary endothelial cells to upregulate adhesion molecules
- is a vasoactive amine
- pre-formed in platelet cells & stored in granules
- by itself can cause most of the symptoms of acute inflammation
- released during platelet activation
-
Binding of which soluble mediator to local sensory nerves binding receptors produces the sensation of pain?
Serotonin
-
Nitric Oxide [NO]
- constitutively expressed by endothelial cells
- causes vascular smooth muscle relaxation - allows blood vessels to dilated
-
What does damage to vascular endothelium cause as a result of decreased NO produced?
- local vasoconstriction --> atherosclerosis
- drug used for treatment: nitroglycerine
-
What other cells can produce nitric oxide?
- leukocytes infiltrating inflamed tissues
- iNOS (inducible nitric oxide synthase) is produced by activated macrophages
- results in additional vasodilation at an infected site; participates in acute inflammation as well*
-
Plasma Proteases
- 1. complement system
- 2. kinin system
- 3. clotting system
- certain cleavage products of each system have important roles in acute inflammation
-
How do C3a and C5a, cleavage products of the Complement System, add to acute inflammation?
- they promote increased vascular permeability and vasodilation by binding to specific complement receptors on mast cells --> releasing histamine
- *C5a is also a chemotactic for leukocytes: promotes their adhesion to endothelium
-
The Kinin System
- potent vasoactive peptides are generated by a cascade of enzymatic reactions following activation of clotting Factor XIIa (12a)
- Factor XII activates Kallekrein which cleaves heavy molecular weight kininogen (HMWK) --> bradykinin
- *activation of individual pathways activates each other
-
bradykinin
- a protein that causes vasodilation and PAIN at a site of inflammation
- made from the cleavage of HMWK by Kallekrein
-
Arachidonic Acid (AA) Metabolism (Eicosanoids)
- after mechanical, physical or biochemical cell stimulation phospholipase A2 is activated and cleaves arachidonic acid from the plasma membrane
- AA is precursor for both inflammatory mediators PG & LT
-
What inhibits phospholipase A2?
- corticosteroids
- therefore no arachidonic acid is cleaved from the phospholipids of the PM, & neither PGs or LTs are made
-
What are the 2 pathways by which AA can be metabolized by?
- 1.Cyclooxygenase pathway: produces prostaglandins
- 2. Lipoxygenase pathway: produces leukotrienes & lipoxins
-
prostaglandins (PG)
- in general cause vasodilation & increased vascular permeability
- PGE2: also causes hyperalgesia (increased sensitivity to pain)
- made from arachidonic acid via the cyclooxygenase pathway
-
leukotrienes (LT)
- cause vasoconstriction & bronchospasm
- typically involved with asthma
- made from arachidonic acid via the lipoxygenase pathway
-
5 lipoxygenase
- enzyme responsible for inducing the lipoxygenase pathway resulting in leukotriene production
- blocking it's activity doesn't completely get rid of asthma because it's a complex disease
-
What 2 enzymes mediate the cyclooxygenase (COX) pathway?
- 1. COX 1
- 2. COX 2
- make prostaglandins
-
COX-1
- cyclooxygenase pathway enzyme constitutively expressed in most tissues (principally by endothelium and to a lesser extent, vascular smooth muscle)
- is thought to be involved in the production of physiologic levels of prostaglandins
-
COX-2
- cyclooxygenase pathway enzymes produced principally by endothelial cells & vascular smooth muscle WITHIN sites of inflammation and tissue trauma
- only produced at sites of trauma because it's upregulated BY WBCs
-
Drugs designed to inhibit COX enzymes
-
Non-selective non-steroidal anti-inflammatory drugs (ns-NSAIDS)
- block BOTH COX-1 AND COX-2
- eg. aspirin, indomethacin, ibuprofen
- take care of inflammation, but also decrease physiologic amounts of PGs
-
Selective NSAIDS (s-NSAIDS)
- Specific for COX-2 and have the benefit of relieving symptoms of acute inflammation WITHOUT the undesirable side effects of
- gastrointestinal ulceration and potential renal damage
- eg. Vioxx and Celebrex
-
LTB4
- type of leukotriene chemotactic for neutrophils & ACTIVATES them
- (remember, general leukotrienes promote vasoconstriction, increased vascular permeability (venules) and bronchospasm
-
LTC4, LTD4, & LTE4
main examples of leukotrienes responsible for vasoconstriction & increased vascular permeability
-
Platelet activating factor (PAF)
- causes vasodilation and increased vascular permeability
- promotes leukocyte adhesion and extravascular trafficking
- *made by activated/infiltrating leukocytes (& other cell types) at the site of inflammation
- may be involved in Type I hypersensitivity reactions
-
Which is more potent at vasodilating, histamine or platelet activating factor?
PAF is 10,000 times more potent than histamine
-
Cytokines
- one way in which cells communicate with each other
- orchestrate + amplify acute inflammatory response locally & systemically
- can exert autocrine, paracrine, & endocrine effects
-
Which cells produce TNF-α and IL-1 (cytokines) in large quantities?
- dendritic cells and macrophages (innate immune system)
- & other cell types at the site of tissue damage
-
Describe the autocrine, paracrine, & endocrine effects of cytokines IL-1 and TNF-α?
- autocrine: IL-1 and TNF-α secreted from a given macrophage may bind its receptors causing more production of itself
- paracrine: bind on endothelial cell receptors in the immediate vicinity of the secreting cell, causing endothelial activation
- endocrine: can be absorbed systemically & promote fever, loss of appetite, neutrophilia, ACTH, & corticosteroid release; induce the formation of acute phase reactant proteins by the liver
-
What other indirect effects does TNF-α posses?
- besides being particularly important in inducing acute inflammation...
- it indirectly promotes the symptoms of endotoxic shock including hypotension, decreased blood pressure, & increased heart rate
- it's seen especially in arthritic joints during fare ups; can help alleviate inflammation by making TNF-α antibodies OR decoy receptors which bind TNF-α & render it unable to have any affect on a target cell
- *people can be more susceptible to infection on such treatment
-
Interleukin 8 (IL-8)
a chemokine that promotes neutrophil recruitment & activation within acutely damaged tissues - is largely responsible for the wave of neutrophils that move to an injured site
-
Where is IL-8 made and stored?
- quiescently IL-8 is made by endothelial cells and stored pre-formed in Weibel-Palade bodies for immediate release upon endothelial cell activation
- it can also be synthesized de novo by macrophages, epithelial cells, or other cells including fibroblasts at the site of tissue injury
|
|